24 | Press release
Notice posted 283 times
Cercare Medical Partners with the European Society of Neuroradiology to Support Perfusion Summit 2027
Published on 09/17/2026, 10:40 AM
.jpg)
AARHUS, DENMARK, 16 September 2026: Cercare Medical, a leader in advanced neuroimaging software, today announced an educational collaboration with the European Society of Neuroradiology (ESNR) in support of Perfusion Summit 2027, the company’s flagship international meeting for perfusion imaging professionals. The Summit will take place 29-30 April 2027 at the Crowne Plaza Linate in Milan, Italy.
Now entering its fourth year, Perfusion Summit has grown into a global meeting point for radiologists, neuroradiologists, and imaging scientists working with perfusion imaging, combining expert presentations, scientific discussion, workshops and international networking. The partnership with ESNR, the leading European professional society dedicated to neuroradiology, strengthens the scientific profile of the event as it moves to Milan for the first time.
The collaboration is designed to benefit both organizations. For ESNR, it extends the Society’s educational reach to an international perfusion imaging audience beyond its own congress channels. For Cercare Medical, ESNR’s endorsement brings added scientific credibility to Perfusion Summit 2027 and deepens its ties to the broader European neuroradiology community.
As part of the agreement, ESNR will endorse Perfusion Summit 2027, and the two organizations will jointly host an educational webinar ahead of the event. ESNR will also help raise awareness of the Summit among its members through its own communication channels. Cercare Medical remains responsible for the full planning, logistics, and scientific program of the event, and will welcome ESNR’s leadership as invited guests in Milan.
"Partnering with ESNR is an important step for Perfusion Summit as we bring the event to Milan for the first time," said Henrik Andersen, Chief Commercial Officer at Cercare Medical. "Their endorsement reflects the growing scientific relevance of perfusion imaging within neuroradiology, and we are excited to welcome ESNR’s community to what has become a truly international meeting point for our field."
Prof. Cem Calli, Vice President at ESNR, added: "Given the promising long-term potential of our collaboration and the excellent relationship we have established with Cercare Medical, we are happy to take this first step together."
Perfusion Summit 2027 will bring together the same international community of imaging professionals that Cercare Medical serves through its CT, MRI, and CBCT perfusion post-processing platform, which supports clinicians working with stroke, oncology, and other neurological conditions worldwide. Participation in the Summit is free of charge, with registration and the full scientific program to be announced in the coming months.
About Cercare Medical
Cercare Medical is a provider of advanced perfusion imaging solutions. With fully automated and multi-vendor compatible software for CT, CBCT, and MRI perfusion imaging post-processing, we are committed to delivering cutting-edge technology that enhances patient care and advances medical diagnostics across various neurological conditions, including Stroke, Oncology, Alzheimer’s, Dementia, and COVID-19. Our proprietary biomarkers allow for better, more precise imaging maps, improving decision-making in critical care and enhancing neuroimaging. This innovative technology has led to widespread adoption by leading hospitals and clinics around the world.
For more information please visit www.cercare-medical.com
Press release issued by M. Khan Martin Published on 09/17/2026, 10:40 AM on 24presse.com
M. Khan Martin
Cercare Medical
www.cercare-medical.com
Contact
Press release free of any broadcasting rights. Please cite the source or provide a link: 24presse.com
Latest press releases in this category "sante"
Cercare Medical Partners with the European Society of N...Published on 09/17/2026, 10:40 AM Théa and Unither Pharmaceuticals Announce Industrial Pa...Published on 07/23/2026, 2:34 PM Cercare Medical Receives FDA 510(k) Clearance for AI Pow...Published on 06/25/2026, 11:38 AM Cercare Medical Receives FDA 510(k) Clearance for Cone-B...Published on 05/29/2026, 11:05 AM Siemens Healthineers and Cercare Medical Announce Global...Published on 05/28/2026, 5:45 PM Cercare Medical Releases Version 18 of Neurosuite: Adva...Published on 02/12/2026, 6:03 PM Cercare Medical Showcases Breakthrough CBCT Perfusion Te...Published on 11/28/2025, 3:49 PM Cercare Medical Releases Version 17 of Neurosuite: Adva...Published on 06/11/2025, 1:55 PM Simbec-Orion acquires major part of the assets of Auxili...Published on 10/05/2021, 5:45 PM The Heart Fund Announces Successful Implementation of Se...Published on 09/29/2021, 12:21 PM